11 AUGUST 2020
Anatara Lifesciences (ASX:ANR) had updated on the initiation of a challenge study in poultry with recently developed bromelain-based formulation (ANR-pf).
Anatara recently said it was finalising discussions with third parties to progress challenge trials of its animal health assets to address barriers to partnering.
The company has entered into an agreement with the University of New England’s Poultry Hub Australia to undertake the study ‘Efficacy of ANR-pf on the performance of broilers subject to subclinical and necrotic enteritis challenges’.
It said the study is anticipated to be completed by 31 January 2021. The project is supported by the Poultry Hub Australia, formerly the Poultry CRC, through funding from AgriFutures Australia as part of its AgriFutures Chicken Meat Program.
Necrotic Enteritis (NE) is the most common and financially devastating bacterial disease in modern broiler flocks.
Please click on the link below for the full article: